Viewing nowRobatarn 20 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Independence Bio-Pharmaceutical Co., Ltd.

MFDS item code 201905537 · Approved 2019.08.06
Treatment of hypercholesterolemia and dyslipidemia (primary, familial) and reduction of cardiovascular disease risk
This medication is primarily used as an adjunct when diet and exercise alone are insufficient for patients with primary hypercholesterolemia and mixed dyslipidemia. It also helps lower cholesterol levels and slow atherosclerosis when used with other treatments in patients with homozygous familial hypercholesterolemia. It is particularly effective in reducing cholesterol and Apo-B protein levels in pediatric patients with heterozygous familial hypercholesterolemia when used alongside dietary changes. Additionally, it is used as an adjunctive therapy for the treatment of primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and vascular revascularization in middle-aged and older individuals at high cardiovascular risk. Overall, this medication plays an important role in the prevention and treatment of cardiovascular diseases.
For patients with primary hypercholesterolemia, mixed dyslipidemia, primary dysbetalipoproteinemia, and homozygous familial hypercholesterolemia, administer 1 dose daily at any time of the day, with or without meals. The initial dose is 5 mg once daily, and the maintenance dose can be adjusted to 10 mg once daily as needed. The maintenance dose should be adjusted appropriately based on LDL cholesterol levels and patient response at intervals of 4 weeks or more.
For pediatric patients with heterozygous familial hypercholesterolemia (aged 10 to 17 years), administer a daily dose of 5 mg to 20 mg, adjusting the dosage at intervals of at least 4 weeks according to treatment goals.
This medication should not be used in certain patients. For instance, patients who are allergic to any components of this medication, those with active liver disease, patients with muscle disorders, those with severe renal impairment, and women who are pregnant or breastfeeding should not take this medication. Moreover, high-dose administration is prohibited for patients at high risk of muscle-related disorders, which include moderate renal impairment, hypothyroidism, a history of genetic muscle diseases, and alcohol dependence. This medication contains lactose, so patients with lactose intolerance should be cautious. Since it can affect liver function, patients with a history of liver disease or those consuming excessive alcohol should have regular liver enzyme tests. If symptoms such as muscle pain, muscle weakness, or muscle cramps occur, immediate consultation with a healthcare provider is necessary, and drug administration may need to be stopped in severe cases. Severe skin reactions may occur, so if symptoms like skin rash, itching, or swelling arise, administration should be discontinued immediately, and a doctor should be consulted. This medication may interact with other drugs; therefore, patients taking specific antivirals, immunosuppressants, antibiotics, or fibrate-class drugs should consult with a specialist. Women who could become pregnant should use appropriate contraceptive methods and avoid taking this medication during pregnancy. Since there is no specific antidote for overdose, treatment should be symptom-based, with liver function and muscle enzyme tests as needed. This medication may cause dizziness while driving or operating machinery, so caution is advised. Lastly, this medication may have higher blood concentrations in Asians, so dosage adjustment may be necessary.
Urticaria, hypersensitivity reactions including angioedema, chest tightness, difficulty breathing, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), jaundice, hepatitis, acute renal failure, oliguria, thrombocytopenia, increased serum creatinine, severe muscle weakness, ocular muscle weakness, immune-mediated necrotizing myopathy, rhabdomyolysis, peripheral neuropathy, memory loss, peripheral neuropathy, interstitial lung disease
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is preferable to maintain storage temperature between 1 degree and 30 degrees Celsius at room temperature.
Pink round film-coated tablet
30 tablets (15 tablets/PTP x 2 units)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Independence Bio-Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.